184 related articles for article (PubMed ID: 22915073)
1. Is the prevalence of ER-negative breast cancer in the US higher among Africa-born than US-born black women?
Jemal A; Fedewa SA
Breast Cancer Res Treat; 2012 Oct; 135(3):867-73. PubMed ID: 22915073
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer subtypes among Eastern-African-born black women and other black women in the United States.
Sung H; DeSantis CE; Fedewa SA; Kantelhardt EJ; Jemal A
Cancer; 2019 Oct; 125(19):3401-3411. PubMed ID: 31190337
[TBL] [Abstract][Full Text] [Related]
3. Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
Medhanie GA; Fedewa SA; Adissu H; DeSantis CE; Siegel RL; Jemal A
Cancer; 2017 Aug; 123(16):3116-3124. PubMed ID: 28407201
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of estrogen receptor-negative breast cancer in Ethiopia.
Kantelhardt EJ; Mathewos A; Aynalem A; Wondemagegnehu T; Jemal A; Vetter M; Knauf E; Reeler A; Bogale S; Thomssen C; Stang A; Gemechu T; Trocchi P; Yonas B
BMC Cancer; 2014 Nov; 14():895. PubMed ID: 25433805
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series.
McCormack VA; Joffe M; van den Berg E; Broeze N; Silva Idos S; Romieu I; Jacobson JS; Neugut AI; Schüz J; Cubasch H
Breast Cancer Res; 2013; 15(5):R84. PubMed ID: 24041225
[TBL] [Abstract][Full Text] [Related]
6. Jim Crow and estrogen-receptor-negative breast cancer: US-born black and white non-Hispanic women, 1992-2012.
Krieger N; Jahn JL; Waterman PD
Cancer Causes Control; 2017 Jan; 28(1):49-59. PubMed ID: 27988896
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Estrogen Receptor Status According to Biological Generation: US Black and White Women Born 1915-1979.
Krieger N; Jahn JL; Waterman PD; Chen JT
Am J Epidemiol; 2018 May; 187(5):960-970. PubMed ID: 29036268
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of breast cancer clinical characteristics and outcome in US black women--effect of place of birth.
Camacho-Rivera M; Kalwar T; Sanmugarajah J; Shapira I; Taioli E
Breast J; 2014; 20(5):489-95. PubMed ID: 25041223
[TBL] [Abstract][Full Text] [Related]
9. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis.
Menashe I; Anderson WF; Jatoi I; Rosenberg PS
J Natl Cancer Inst; 2009 Jul; 101(14):993-1000. PubMed ID: 19584327
[TBL] [Abstract][Full Text] [Related]
10. Receipt of surgical treatment in US women with early stage breast cancer: does place of birth matter?
Chavan S; Goodman M; Jemal A; Fedewa SA
Ethn Dis; 2014; 24(1):110-5. PubMed ID: 24620457
[TBL] [Abstract][Full Text] [Related]
11. Temporal trends in the black/white breast cancer case ratio for estrogen receptor status: disparities are historically contingent, not innate.
Krieger N; Chen JT; Waterman PD
Cancer Causes Control; 2011 Mar; 22(3):511-4. PubMed ID: 21188492
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer disease severity and country of origin among black men in the United States.
Fedewa SA; Jemal A
Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):176-80. PubMed ID: 23338555
[TBL] [Abstract][Full Text] [Related]
13. Influence of nativity status on breast cancer risk among US black women.
Borrell LN; Castor D; Conway FP; Terry MB
J Urban Health; 2006 Mar; 83(2):211-20. PubMed ID: 16736370
[TBL] [Abstract][Full Text] [Related]
14. Associations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situ.
Dania V; Liu Y; Ademuyiwa F; Weber JD; Colditz GA
Breast Cancer Res; 2019 Nov; 21(1):120. PubMed ID: 31727116
[TBL] [Abstract][Full Text] [Related]
15. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
[TBL] [Abstract][Full Text] [Related]
16. Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women.
Barber LE; Zirpoli GR; Cozier YC; Rosenberg L; Petrick JL; Bertrand KA; Palmer JR
Breast Cancer Res; 2021 Nov; 23(1):108. PubMed ID: 34809694
[TBL] [Abstract][Full Text] [Related]
17. The greater impact of menopause on ER- than ER+ breast cancer incidence: a possible explanation (United States).
Tarone RE; Chu KC
Cancer Causes Control; 2002 Feb; 13(1):7-14. PubMed ID: 11899120
[TBL] [Abstract][Full Text] [Related]
18. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of triple-negative tumors in an urban cancer center.
Lund MJ; Butler EN; Bumpers HL; Okoli J; Rizzo M; Hatchett N; Green VL; Brawley OW; Oprea-Ilies GM; Gabram SG
Cancer; 2008 Aug; 113(3):608-15. PubMed ID: 18484596
[TBL] [Abstract][Full Text] [Related]
20. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
